Cipla Limited (CIPLA) — Announcement
· NSE
🔴 High Importance
Neutral
📢 Key Event
Cipla submits routine regulatory update to NSE
💡 Investor Takeaway
This filing signals stability but lacks new information for investment decisions.
No summary available
About Cipla Limited (CIPLA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,15,682.55 Cr
P/E: 25.4
ROE: 14.6%
ROCE: 19.4%
Recent Announcements from Cipla Limited
-
Announcement — 12 July 2026
Cipla announced that Crisil ESG Ratings assigned it a Crisil ESG 69 and Crisil Core ESG 66 rating, received on 11 July 2026, as part of its compliance... -
🟡 Board Meeting — 4 July 2026
Cipla held its 90th AGM on 25 June 2026, highlighting ₹28,000+ crores revenue, 21% EBITDA margin, and [amount context mismatch] final dividend. Shareh... -
🟡 Board Meeting — 3 July 2026
Cipla held its 90th AGM on 25 June 2026, approving financial results, auditor appointments, and leadership changes, including Mr Achin Gupta as new MD... -
🟡 Board Meeting — 25 June 2026
Cipla announced the appointment of B S R & Co. LLP as its new statutory auditor for a five-year term starting from the conclusion of its 90th AGM on 2... -
🟡 Board Meeting — 25 June 2026
Cipla held its 90th Annual General Meeting on 25 June 2026 via video conference, adopting audited standalone and consolidated financial statements for...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when CIPLA files new disclosures
Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CIPLA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research